September 04, 2025 a 07:43 am

HOLX: Fundamental Ratio Analysis - Hologic, Inc.

Hologic, Inc. stock overview

Hologic, Inc. is primarily engaged in healthcare solutions focusing on women's health. Although the company displays a steady growth potential in diagnostics and imaging, the stock's valuation metrics warrant a cautious approach due to the current market conditions.

Fundamental Rating

The fundamental rating for Hologic, Inc. presents a balanced scorecard, emphasizing its strengths in certain financial aspects, while also highlighting potential risks.

Category Score Visualization
Discounted Cash Flow 5
Return On Equity 4
Return On Assets 4
Debt To Equity 2
Price To Earnings 1
Price To Book 2

Historisches Rating

Recent historical data indicates a consistent rating over the past period, with a noticeable mention of past achievements.

Date Overall Score DCF ROE ROA D/E P/E P/B
2025-09-03 3 5 4 4 2 1 2
Historical 0 5 4 4 2 1 2

Analysten-Kursziele

Analyst price targets suggest a promising outlook with measured optimism, reflecting both high and median expectations.

High Low Median Consensus
$75 $65 $70 $70
Stock chart of Hologic, Inc.

Analystenstimmung

The sentiment among analysts highlights a predominantly positive stance, with an emphasis on buy recommendations.

Recommendation Count Visualization
Strong Buy 0
Buy 23
Hold 18
Sell 1
Strong Sell 0

Conclusion

Hologic, Inc. demonstrates solid performance in various financial metrics adhering to a generally favorable analyst sentiment. However, some valuation metrics suggest potential overvaluation, which introduces a level of risk. The consistent historical performance underscores stability in operations, balanced by future opportunities in diagnostics and imaging expansion. Investors should weigh these factors against current market volatility. Overall, Hologic remains a viable option for those focused on the healthcare sector.